.svg)
Real-world evaluation of cellular, acellular, and matrix-like products for pressure ulcers in the post-acute setting
This observational comparative effectiveness study analyzed de-identified data from the LiftOff Registry, a national database encompassing more than 18,000 patients and 23,000 pressure ulcers (PUs) treated in long-term acute care hospitals and skilled nursing facilities.
Zwelithini Tunyiswa,1 | Ryan Dirks,2 MS, PA, CWS | Howard Walthall,3
1Open Wound Research, Puyallup, WA, USA| 2United Wound Healing, Puyallup WA, USA | 3Venture Medical, Missoula, Montana, USA
Correspondence: Zwelithini Tunyiswa (zweli@openwoundresearch.com)
Received: 22 October 2025 | Accepted: 26 October 2025
Funding: Open-access publication of this article was supported by Venture Medical. The funder had no additional influence on the study design, data collection, analysis, or interpretation.
Keywords: Pressure ulcer | post acute care | cellular, acellular and matrix-like products | real-world evidence | Bayesian analysis
Download PDF Of The Article:
https://internationaljournaloftissuerepair.com/index.php/ijtr/article/view/28/31
Popular Research
Categories
Human keratin matrix use and wound healing outcomes in post-acute care of pressure ulcers: Evidence from a Bayesian real-world study
In this real-world post-acute care cohort of patients with PUs, HKM use was associated with a high posterior probability of improved healing compared with SOC alone. These findings support HKM as an adjunctive therapy for complex or non-healing pressure ulcers in post-acute care settings.
A multicentre clinical trial evaluating the outcomes of two application regimens of a unique keratin-based graft in the treatment of Wagner grade one non-healing diabetic foot ulcers
Based on these results, future studies should be conducted that further investigate the use of this novel human keratin matrix graft for the treatment of chronic DFUs.
Retention processed placental membrane versus standard of care in treating diabetic foot ulcers
Diabetic foot ulcers (DFUs) are a severe complication for diabetic patients, significantly impacting patient quality of life and healthcare system efficiency. Traditional standard of care (SOC) treatments are inadequate for many patients, necessitating the use of advanced wound care products, such as human placental membranes.
A multicentre clinical trial evaluating the outcomes of two application regimens of a unique keratin-based graft in the treatment of Wagner grade one non-healing diabetic foot ulcers
Diabetic foot complications that lead to lower extremity amputations pose a significant challenge to the entire global health system.
Assessing placental membrane treatment efficiency in diabetic foot ulcers: Processing for retention versus lamination
Diabetic foot ulcers are a severe complication in diabetic patients, significantly impact healthcare systems and patient quality of life, often leading to hospitalization and amputation.
